The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index, and 1 are not checked yet.
Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine
Open accessAbstract
Monamines subserve many critical roles in the brain, and monoaminergic drugs such as amphetamine have a long history in the treatment of neuropsychiatric disorders and also as a substance of abuse. The clinical effects of amphetamine are quite variable, from positive effects on mood and cognition in some individuals, to negative responses in others, perhaps related to individual variations in monaminergic function and monoamine system genes. We explored the effect of a functional polymorphism ( val 158 -met ) in the catechol O -methyltransferase gene, which has been shown to modulate prefrontal dopamine in animals and prefrontal cortical function in humans, on the modulatory actions of amphetamine on the prefrontal cortex. Amphetamine enhanced the efficiency of prefrontal cortex function assayed with functional MRI during a working memory task in subjects with the high enzyme activity val / val genotype, who presumably have relatively less prefrontal synaptic dopamine, at all levels of task difficulty. In contrast, in subjects with the low activity met / met genotype who tend to have superior baseline prefrontal function, the drug had no effect on cortical efficiency at low-to-moderate working memory load and caused deterioration at high working memory load. These data illustrate an application of functional neuroimaging in pharmacogenomics and extend basic evidence of an inverted-“U” functional-response curve to increasing dopamine signaling in the prefrontal cortex. Further, individuals with the met / met catechol O -methyltransferase genotype appear to be at increased risk for an adverse response to amphetamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that WM performance in psychotic and healthy subjects rely on dopamine levels within the PFC (Dumontheil et al., 2011; Mattay et al., 2003; Okubo et al., 1997).”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Mattay et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“some human participants who had lower baseline dopamine levels (due to Val/Val allele in COMT gene), showed improved WM performance after dexamphetamine administration, while others who had a higher dopamine level (met/met allele subjects) showed the opposite effect”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Mattay et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, methionine substitutions in COMT increase the stress response in mice75 and make humans more susceptible to cognitive impairment following stress and psychostimulant medication74.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [74]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the methionine substitution in the COMT protein that results from one of the COMT polymorphisms reduces the ability of COMT to catabolize dopamine and increases vulnerability to stress- or stimulant-induced working memory impairments in human subjects74 and in mice75.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurophysiological investigation of the basis of the fMRI signal
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001) · Nature · doi:10.1038/35084005 · Cited by 6,551
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citationModulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593
Allelic discrimination using fluorogenic probes and the 5' nuclease assay.
Livak, K. (1999) · Genetic Analysis, Techniques and Applications (GATA) · doi:10.1016/s1050-3862(98)00019-9 · Cited by 1,352
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Allelic discrimination using fluorogenic probes and the 5' nuclease assay
Foitzi, T. (1999) · Medical Entomology and Zoology · Cited by 783
Callicott, J. H. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.1.20 · Cited by 771
Self-citation
Research works printed but not linked: 1
- P Mannisto, S Kaakkola Pharmacol Rev 51, 593–628 (1999).
Cited by
Sorted by citations
Items 101–200 of 893
Tan, H. Y., Nicodemus, K. K., Chen, Q., Li, Z., Brooke, J. K., Honea, R. A., Kolachana, B. S., Straub, R. E., Meyer‐Lindenberg, A., Sei, Y., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34725 · Cited by 199
Self-citationUrsini, G., Bollati, V., Fazio, L., Porcelli, A., Iacovelli, L., Catalani, A., Sinibaldi, L., Gelao, B., Romano, R., Rampino, A., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6631-10.2011 · Cited by 188
The role of fMRI in drug discovery
Wise, R. G., & Tracey, I. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20584 · Cited by 186
Thiel, C. M., Zilles, K., & Fink, G. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300633 · Cited by 182
Warriors Versus Worriers: The Role of COMT Gene Variants
Stein, D. J., Newman, T. K., Savitz, J. B., & Ramesar, R. (2006) · CNS Spectrums · doi:10.1017/s1092852900014863 · Cited by 182
Williams‐Gray, C. H., Hampshire, A., Robbins, T. W., Owen, A. M., & Barker, R. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0774-07.2007 · Cited by 181
Is COMT a Susceptibility Gene for Schizophrenia?
Williams, H. J., Owen, M. J., & O’Donovan, M. C. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm019 · Cited by 181
Improving executive function using transcranial infrared laser stimulation
Blanco, N. J., Maddox, W. T., & Gonzalez‐Lima, F. (2017) · Journal of Neuropsychology · doi:10.1111/jnp.12074 · Cited by 179
Assessing cognitive function in clinical trials of schizophrenia
Barnett, J. H., Robbins, T. W., Leeson, V. C., Sahakian, B. J., Joyce, E. M., & Blackwell, A. D. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.012 · Cited by 178
Effects of COMT polymorphisms on brain function and behavior in health and disease
Witte, A. V., & Flöel, A. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.012 · Cited by 183
Tan, H. Y., Chen, Q., Sust, S., Buckholtz, J. W., Meyers, J. D., Egan, M. F., Mattay, V. S., Meyer‐Lindenberg, A., Weinberger, D. R., & Callicott, J. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610125104 · Cited by 174
Self-citationThe effects of background white noise on memory performance in inattentive school children
Söderlund, G. B. W., Sikström, S., Loftesnes, J. M., & Sonuga-Barke, E. J. S. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-55 · Cited by 175
Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome
Raux, G., Bumsel, E., Hecketsweiler, B., van Amelsvoort, T., Zinkstok, J., Manouvrier‐Hanu, S., Fantini‐Hauwel, C., Brèviere, G., Rosa, G. D., Pustorino, G., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl443 · Cited by 170
Dosage-dependent non-linear effect of l -dopa on human motor cortex plasticity
Monte-Silva, K. K., Liebetanz, D., Grundey, J., Paulus, W., & Nitsche, M. A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.190181 · Cited by 177
Insights into the Role of Dopamine Receptor Systems in Learning and Memory
El-Ghundi, M., O’Dowd, B. F., & George, S. R. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.1.37 · Cited by 174
Prefrontal-Hippocampal Coupling During Memory Processing Is Modulated by COMT Val158Met Genotype
Bertolino, A., Rubino, V., Sambataro, F., Blasi, G., Latorre, V., Fazio, L., Caforio, G., Petruzzella, V., Kolachana, B. S., Hariri, A. R., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.078 · Cited by 174
Self-citationBarch, D. M., & Carter, C. S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.019 · Cited by 222
Takahashi, H., Kato, M., Takano, H., Arakawa, R., Okumura, M., Otsuka, T., Kodaka, F., Hayashi, M., Okubo, Y., Ito, H., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3446-08.2008 · Cited by 167
Attentional control in Parkinson's disease is dependent on COMT val158met genotype
Williams‐Gray, C. H., Hampshire, A., Barker, R., & Owen, A. M. (2008) · Brain · doi:10.1093/brain/awm313 · Cited by 165
Influence of the COMT genotype on working memory and brain activity changes during development
Dumontheil, I., Roggeman, C., Ziermans, T., Peyrard-Janvid, M., Matsson, H., Kere, J., & Klingberg, T. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.027 · Cited by 165
Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people
Ilieva, I. P., Boland, J. R., & Farah, M. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.021 · Cited by 171
Neuromodulation and aging: implications of aging neuronal gain control on cognition
Li, S., & Rieckmann, A. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.07.009 · Cited by 172
Methamphetamine Activates Reward Circuitry in Drug Naïve Human Subjects
Vӧllm, B., de Araújo, I. E., Cowen, P. J., Rolls, E. T., Kringelbach, M. L., Smith, K., Jezzard, P., Heal, R. J., & Matthews, P. M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300481 · Cited by 160
Meta‐analysis of COMT val158met in panic disorder: Ethnic heterogeneity and gender specificity
Domschke, K., Deckert, J., O’Donovan, M. C., & Glatt, S. J. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30494 · Cited by 157
Investigating the dopaminergic basis of extraversion in humans: A multilevel approach.
Wacker, J., Chavanon, M., & Stemmler, G. (2006) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.91.1.171 · Cited by 163
Ilieva, I. P., Hook, C. J., & Farah, M. J. (2015) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00776 · Cited by 166
Individual Differences and State-Dependent Responses in Transcranial Direct Current Stimulation
Hsu, T., Juan, C.-H., & Tseng, P. H. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00643 · Cited by 152
O’Tuathaigh, C. M. P., Babovic, D., O’Meara, G. F., Clifford, J. J., Croke, D. T., & Waddington, J. L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.04.002 · Cited by 154
COMT Val108/158Met Modifies Mismatch Negativity and Cognitive Function in 22q11 Deletion Syndrome
Baker, K., Baldeweg, T., Sivagnanasundaram, S., Scambler, P. J., & Skuse, D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.020 · Cited by 150
Heinz, A., & Smolka, M. N. (2006) · Reviews in the Neurosciences · doi:10.1515/revneuro.2006.17.3.359 · Cited by 148
Dopamine Supports Coupling of Attention-Related Networks
Dang, L. C., O’Neil, J. P., & Jagust, W. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0909-12.2012 · Cited by 148
Chemistry of the Adaptive Mind: Lessons from Dopamine
Cools, R. (2019) · Neuron · doi:10.1016/j.neuron.2019.09.035 · Cited by 150
Stewart, C. V., & Plenz, D. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0723-06.2006 · Cited by 147
Kelly, C. A. M., Foxe, J. J., & Garavan, H. (2006) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2006.08.333 · Cited by 154
Genes Associated With Addiction: Alcoholism, Opiate, and Cocaine Addiction
Kreek, M. J., Nielsen, D. A., & LaForge, K. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:085 · Cited by 149
Tan, H.-Y., Chen, Q., Goldberg, T. E., Mattay, V. S., Meyer-Lindenberg, A., Weinberger, D. R., & Callicott, J. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4041-07.2007 · Cited by 144
Self-citationCOMT Gene Polymorphism Is Associated with Declarative Memory in Adulthood and Old Age
de Frias, C. M., Annerbrink, K., Westberg, L., Eriksson, E., Adolfsson, R., & Nilsson, L.-G. (2004) · Behavior Genetics · doi:10.1023/b:bege.0000038491.06972.8c · Cited by 145
Association of the COMT val158met Variant with Antidepressant Treatment Response in Major Depression
Baune, B. T., Hohoff, C., Berger, K., Neumann, A., Mortensen, S., Roehrs, T., Deckert, J., Arolt, V., & Domschke, K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301462 · Cited by 149
A Neurogenetic Approach to Impulsivity
Congdon, E. L., & Canli, T. (2008) · Journal of Personality · doi:10.1111/j.1467-6494.2008.00528.x · Cited by 150
Kirsch, P., Reuter, M., Mier, D. U., Lonsdorf, T. B., Stark, R. M., Gallhofer, B., Vaitl, D., & Hennig, J. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.030 · Cited by 144
Farrell, S., Tunbridge, E. M., Braeutigam, S., & Harrison, P. J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.023 · Cited by 150
GIBBS, S. E. B., & D'ESPOSITO, M. (2005) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/cabn.5.2.212 · Cited by 145
Nicodemus, K. K., Kolachana, B. S., Vakkalanka, R., Straub, R. E., Giegling, I., Egan, M. F., Rujescu, D., & Weinberger, D. R. (2006) · Human Genetics · doi:10.1007/s00439-006-0257-3 · Cited by 145
Self-citationDopamine and psychosis: Theory, pathomechanisms and intermediate phenotypes
Tost, H., Alam, T., & Meyer-Lindenberg, A. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.005 · Cited by 160
Bertolino, A., Fazio, L., Caforio, G., Blasi, G., Rampino, A., Romano, R., Giorgio, A. D., Taurisano, P., Papp, A. C., Pinsonneault, J. K., et al. (2008) · Brain · doi:10.1093/brain/awn248 · Cited by 142
Schizophrenia: From developmental deviance to dopamine dysregulation
Murray, R. M., Lappin, J., & Forti, M. D. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.04.002 · Cited by 142
Hirth, N., Meinhardt, M. W., Noori, H. R., Salgado, H., Torres‐Ramírez, O., Uhrig, S., Broccoli, L., Vengeliene, V., Roßmanith, M., Perreau‐Lenz, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506012113 · Cited by 151
Dopamine Transporter Gene Associated with Diminished Subjective Response to Amphetamine
Lott, D. C., Kim, S., Cook, E. H., & de Wit, H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300637 · Cited by 138
Schweitzer, J. B., Lee, D. O., Hanford, R. B., Zink, C. F., Ely, T. D., Tagamets, M. A., Hoffman, J. M., Grafton, S. T., & Kilts, C. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.011 · Cited by 135
On the Origin of Cortical Dopamine: Is it a Co-Transmitter in Noradrenergic Neurons?
Devoto, P., & Flore, G. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359559 · Cited by 137
Qin (2011) · doi:10.1016/j.neuroimage.2011.05.006 · Cited by 124
Self-citationde Frias, C. M., Annerbrink, K., Westberg, L., Eriksson, E., Adolfsson, R., & Nilsson, L. (2005) · Journal of Cognitive Neuroscience · doi:10.1162/0898929054475136 · Cited by 141
Stice, E. M., Yokum, S., Burger, K., Epstein, L. H., & Smolen, A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1506-12.2012 · Cited by 136
Prescription stimulant medication misuse: Where are we and where do we go from here?
Weyandt, L. L., Oster, D. R., Marraccini, M. E., Guðmundsdóttir, B. G., Munro, B. A., Rathkey, E. S., & McCallum, A. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000093 · Cited by 138
Tuning the engine of cognition: A focus on NMDA/D1 receptor interactions in prefrontal cortex
Castner, S. A., & Williams, G. V. (2007) · Brain and Cognition · doi:10.1016/j.bandc.2006.11.002 · Cited by 134
Matsumoto, M., Weickert, C. S., Beltaifa, S., Kolachana, B. S., Chen, J., Hyde, T. M., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300218 · Cited by 133
Self-citationDevelopment and function of the midbrain dopamine system: what we know and what we need to
Bissonette, G. B., & Roesch, M. R. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12257 · Cited by 141
Giakoumaki, S. G., Roussos, P., & Bitsios, P. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.82 · Cited by 136
The promise and predicament of cosmetic neurology
Chatterjee, A. K. (2006) · Journal of Medical Ethics · doi:10.1136/jme.2005.013599 · Cited by 128
Genetics and Epigenetics in Major Psychiatric Disorders
Abdolmaleky, H. M., Thiagalingam, S., & Wilcox, M. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505030-00002 · Cited by 134
Gjedde, A., Kumakura, Y., Cumming, P., Linnet, J., & Møller, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912319107 · Cited by 130
Weickert, T. W., Goldberg, T. E., Mishara, A. L., Apud, J. A., Kolachana, B. S., Egan, M. F., & Weinberger, D. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.012 · Cited by 130
Self-citationSchott, B. H., Sellner, D., Lauer, C., Habib, R., Frey, J. U., Guderian, S., Heinze, H., & Düzel, E. (2004) · Learning & Memory · doi:10.1101/lm.75004 · Cited by 126
Diaz-Asper, C. M., Goldberg, T. E., Kolachana, B. S., Straub, R. E., Egan, M. F., & Weinberger, D. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.031 · Cited by 134
Self-citationConsequences of Variations in Genes that affect Dopamine in Prefrontal Cortex
Diamond, A. D. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm082 · Cited by 132
Impact of interacting functional variants in COMT on regional gray matter volume in human brain
Honea, R., Verchinski, B. A., Pezawas, L., Kolachana, B. S., Callicott, J. H., Mattay, V. S., Weinberger, D. R., & Meyer-Lindenberg, A. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.064 · Cited by 128
Self-citationAdrenergic targets for the treatment of cognitive deficits in schizophrenia
Arnsten, A. F. T. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1724-3 · Cited by 128
Genes, brain development and psychiatric phenotypes in velo‐cardio‐facial syndrome
Gothelf, D., Schaer, M., & D, S. E. M. (2008) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.9 · Cited by 127
Human cognitive flexibility depends on dopamine D2 receptor signaling
van Holstein, M., Aarts, E., van der Schaaf, M. E., Geurts, D. E. M., Verkes, R. J., Franke, B., van Schouwenburg, M. R., & Cools, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2340-2 · Cited by 133
Erickson, K. I. (2008) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.011.2008 · Cited by 124
Chen, X., Wang, X., O’Neill, F. A., Walsh, D., & Kendler, K. S. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001519 · Cited by 125
Stress matters: randomized controlled trial on the effect of probiotics on neurocognition
Papalini, S., Michels, F., Kohn, N., Wegman, J., van Hemert, S., Roelofs, K., Arias-Vasquez, A., & Aarts, E. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.100141 · Cited by 123
Molecular genetic studies of ADHD and its candidate genes: A review
Li, Z., Chang, S., Zhang, L., Gao, L., & Wang, J. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.05.005 · Cited by 136
COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits
Winterer, G., Musso, F., Vučurević, G., Stoeter, P., Konrad, A., Seker, B., Gallinat, J., Dahmen, N., & Weinberger, D. R. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.05.058 · Cited by 123
Self-citationRecovery of function in humans: Cortical stimulation and pharmacological treatments after stroke
Flöel, A., & Cohen, L. G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.027 · Cited by 123
Planning ability in Parkinson's disease is influenced by the COMT val 158 met polymorphism
Foltynie, T., Goldberg, T. E., Lewis, S. J. G., Blackwell, A. D., Kolachana, B. S., Weinberger, D. R., Robbins, T. W., & Barker, R. A. (2004) · Movement Disorders · doi:10.1002/mds.20118 · Cited by 122
Self-citationAmphetamine modulates brain signal variability and working memory in younger and older adults
Garrett, D. D., Nagel, I. E., Preuschhof, C., Burzynska, A. Z., Marchner, J., Wiegert, S., Jungehülsing, G. J., Nyberg, L., Villringer, A., Li, S.-C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504090112 · Cited by 103
Pearson‐Fuhrhop, K. M., Minton, B. R., Acevedo, D., Shahbaba, B., & Cramer, S. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061197 · Cited by 126
Neuroeconomics and aging: Neuromodulation of economic decision making in old age
Mohr, P. N. C., Li, S., & Heekeren, H. R. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.05.010 · Cited by 119
Dopamine D1 receptors and age differences in brain activation during working memory
Bäckman, L., Karlsson, S., Fischer, H., Karlsson, P., Brehmer, Y., Rieckmann, A., MacDonald, S. W. S., Farde, L., & Nyberg, L. H. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.018 · Cited by 125
From an Executive Network to Executive Control: A Computational Model of the n-back Task
Chatham, C. H., Herd, S. A., Brant, A. M., Hazy, T. E., Miyake, A., O'Reilly, R., & Friedman, N. P. (2011) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00047 · Cited by 115
del Campo, N., Fryer, T. D., Hong, Y. T., Smith, R., Brichard, L., Acosta-Cabronero, J., Chamberlain, S. R., Tait, R., Izquierdo, D., Regenthal, R., et al. (2013) · Brain · doi:10.1093/brain/awt263 · Cited by 113
Schizotypal Personality Disorder
Chemerinski, E., Triebwasser, J., Roussos, P., & Siever, L. J. (2012) · Journal of Personality Disorders · doi:10.1521/pedi_2012_26_053 · Cited by 117
Functional Magnetic Resonance Imaging
Fink, G. R. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50079-7 · Cited by 114
Dodds, C. M., Muller, U., Clark, L., van Loon, A., Cools, R., & Robbins, T. W. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1153-08.2008 · Cited by 113
van Schouwenburg, M. R., Aarts, E., & Cools, R. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791293097 · Cited by 118
When we enhance cognition with Adderall, do we sacrifice creativity? A preliminary study
Farah, M. J., Haimm, C., Sankoorikal, G. M. V., & Chatterjee, A. K. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1369-3 · Cited by 113
Cerovecki, A., Musil, R., Klimke, A., Seemüller, F., Haen, E., Schennach, R., Kühn, K.-U., Volz, H.-P., & Riedel, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0079-5 · Cited by 112
Congdon, E. L., & Canli, T. (2005) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582305285980 · Cited by 109
Hamidovic, A., Dlugos, A., Skol, A., Palmer, A. A., & de Wit, H. (2009) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0017840 · Cited by 108
DURSTON, S., FOSSELLA, J. A., MULDER, M. J., CASEY, B. J., ZIERMANS, T. B., VESSAZ, M. N., & VAN ENGELAND, H. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815a5f17 · Cited by 108
The effect of hypercapnia on the neural and hemodynamic responses to somatosensory stimulation
Jones, M., Berwick, J., Hewson-Stoate, N., Gias, C., & Mayhew, J. E. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.04.036 · Cited by 106
Influence of SLC6A3 and COMT variation on neural activation during response inhibition
Congdon, E., Constable, R. T., Lesch, K. P., & Canli, T. (2009) · Biological Psychology · doi:10.1016/j.biopsycho.2009.03.005 · Cited by 103
COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review
Schacht, J. P. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.43 · Cited by 108
Yuferov, V. P., Levran, O., Proudnikov, D., Nielsen, D. A., & Kreek, M. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05275.x · Cited by 106
Lyon, L., Saksida, L. M., & Bussey, T. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2536-5 · Cited by 107
Association analysis of the DRD4 and COMT genes in methamphetamine abuse
Li, T., Chen, C. Y., Hu, X., Ball, D., Lin, S., Chen, W., Sham, P. C., Loh, E., Murray, R. M., & Collier, D. A. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30024 · Cited by 108
Dopaminergic modulation of cognition across the life span
Li, S., Lindenberger, U., & Bäckman, L. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.003 · Cited by 104
O’Tuathaigh, C. M. P., Hryniewiecka, M., Behan, Á. T., Tighe, O., Coughlan, C. A., Desbonnet, L., Cannon, M. D., Karayiorgou, M., Gogos, J. A., Cotter, D., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.100 · Cited by 103
Bertolino, A., Fazio, L., Giorgio, A. D., Blasi, G., Romano, R., Taurisano, P., Caforio, G., Sinibaldi, L., Ursini, G., Popolizio, T., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4858-08.2009 · Cited by 102
Metadata
- Authors
- Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-04-25
- Volume
- 100
- Issue
- 10
- Pages
- 6186-6191
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC156347
- OpenAlex
- W2123636362
- Cited by
- 893
- References
- 36
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 10 · 2020: 19 · 2019: 13 · 2018: 17 · 2017: 30 · 2016: 34 · 2015: 51 · 2014: 50 · 2013: 66 · 2012: 61
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- catechol-O-methyltransferase, COMT Val158Met polymorphism, amphetamine, prefrontal cortex, working memory, dopamine signaling, pharmacogenomics, individual differences, monoaminergic systems
- MeSH terms
- Brain, Catechol O-Methyltransferase, Dextroamphetamine, DNA, Genotype, Humans, Magnetic Resonance Imaging, Methionine, Organ Specificity, Valine, Amino Acid Substitution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
